- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期行情可能回暖，可适量买进股票，作短线反弹行情。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有1家主力机构披露2025-12-31报告期持股数据，持仓量总计7.20万股，占流通A股0.01%
- 波段诊断：
-
技术面诊股
诊断结果：4.8技术面打败了23%的股票
技术面评分前10的股票
近期的平均成本为9.59元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为9.59元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"9.59","date":1772698188,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2026.03.06","stock":"2.34","trade":"3.05","ind":"0.59"},{"date":"2026.03.05","stock":"1.18","trade":"0.79","ind":"1.23"},{"date":"2026.03.04","stock":"-1.79","trade":"-0.84","ind":"-0.75"},{"date":"2026.03.03","stock":"-2.37","trade":"-2.99","ind":"-3.07"},{"date":"2026.03.02","stock":"-3.09","trade":"-2.61","ind":"-0.20"},{"date":"2026.02.27","stock":"0.20","trade":"0.28","ind":"-0.06"},{"date":"2026.02.26","stock":"-0.50","trade":"-0.72","ind":"0.19"},{"date":"2026.02.25","stock":"0.90","trade":"1.27","ind":"1.29"},{"date":"2026.02.24","stock":"1.53","trade":"0.43","ind":"1.36"},{"date":"2026.02.13","stock":"-1.51","trade":"-0.55","ind":"-1.28"},{"date":"2026.02.12","stock":"-0.40","trade":"-0.47","ind":"0.86"},{"date":"2026.02.11","stock":"-0.50","trade":"-0.58","ind":"-0.35"},{"date":"2026.02.10","stock":"0.00","trade":"0.30","ind":"0.02"},{"date":"2026.02.09","stock":"0.40","trade":"0.78","ind":"2.17"},{"date":"2026.02.06","stock":"0.70","trade":"0.22","ind":"-0.33"},{"date":"2026.02.05","stock":"-0.90","trade":"-0.38","ind":"-1.44"},{"date":"2026.02.04","stock":"0.40","trade":"0.70","ind":"2.40"},{"date":"2026.02.02","stock":"-2.88","trade":"-2.66","ind":"-2.69"},{"date":"2026.01.30","stock":"-1.66","trade":"-1.26","ind":"-0.66"},{"date":"2026.01.29","stock":"-1.54","trade":"-1.58","ind":"-0.30"},{"date":"2026.01.28","stock":"-0.67","trade":null,"ind":"0.09"}]
安科生物,深证成指,生物制品指数
压力支撑
该股压力位为9.47元，支撑位为9.30元。
[{"text":"\u538b\u529b\u4f4d","value":"9.47","date":1772726400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"9.30","date":1772726400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.8资金面打败了5%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：03月06日 20:30
| 机构今日流向(万元) | 2623.55 | 机构5日流向(万元) | -5068.76 |
| 机构10日流向(万元) | -8734.74 | 机构20日流向(万元) | -19828.22 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少13361.8万股，其中基金数没有增加，主力净减仓174家，请投资者中长期谨慎为宜。
截止2025-12-31，共1家主力机构（基金1家），持仓量总计7.20万股，占流通A股0.01%
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有7.2万股
从主力名单中消失：175家 ，原持有13369万股
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有7.2万股
从主力名单中消失：175家 ，原持有13369万股
消息面诊股
诊断结果：5.5消息面打败了38%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 安科生物：参股公司PA3-17注射液新增适应症临床
2026-03-06 - 安科生物：3月5日获融资买入1349.93万元
2026-03-06 - 多家药企密集发布利好公告 研发与合规布局持续推进
2026-03-05 - 重磅BD交易催化，创新药ETF涨1.21%
2026-03-05 - 安科生物：3月4日获融资买入1561.04万元
2026-03-05 - 安科生物：PA3-17注射液新增适应症获临床试验批
2026-03-04 - 安科生物：3月2日获融资买入3402.67万元
2026-03-03 - 安科生物获13家机构调研：公司自主研发的“AK20
2026-03-03 - 安科生物：2月27日获融资买入2303.57万元
2026-03-02 - 安科生物：2月26日获融资买入1743.32万元
2026-02-27
消息列表
| 一般消息 | 高管变动 | 任期届满后离任 | 2025-12-18 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-26 |
| 一般消息 | 重大事项 | 关联交易 | 2025-11-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2025-03-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.7行业面打败了79%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.03.06","price":"0.59","value":"3.05"},{"date":"2026.03.05","price":"1.23","value":"0.79"},{"date":"2026.03.04","price":"-0.75","value":"-0.84"},{"date":"2026.03.03","price":"-3.07","value":"-2.99"},{"date":"2026.03.02","price":"-0.20","value":"-2.61"},{"date":"2026.02.27","price":"-0.06","value":"0.28"},{"date":"2026.02.26","price":"0.19","value":"-0.72"},{"date":"2026.02.25","price":"1.29","value":"1.27"},{"date":"2026.02.24","price":"1.36","value":"0.43"},{"date":"2026.02.13","price":"-1.28","value":"-0.55"},{"date":"2026.02.12","price":"0.86","value":"-0.47"},{"date":"2026.02.11","price":"-0.35","value":"-0.58"},{"date":"2026.02.10","price":"0.02","value":"0.30"},{"date":"2026.02.09","price":"2.17","value":"0.78"},{"date":"2026.02.06","price":"-0.33","value":"0.22"},{"date":"2026.02.05","price":"-1.44","value":"-0.38"},{"date":"2026.02.04","price":"2.40","value":"0.70"},{"date":"2026.02.02","price":"-2.69","value":"1.66"},{"date":"2026.01.30","price":"-0.66","value":"-2.66"},{"date":"2026.01.29","price":"-0.30","value":"-1.26"},{"date":"2026.01.28","price":"0.09","value":"-1.58"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万泽股份 | 33.42% | -1.46% | 6.6分 |
| 2 | 欧林生物 | 16.54% | 3.78% | 6.1分 |
| 3 | ST未名 | 14.30% | 1.79% | 5.2分 |
| 4 | 诺诚健华 | 12.56% | -2.66% | 5.0分 |
| 5 | *ST四环 | 6.84% | 1.81% | 6.1分 |
| 6 | - | 5.23% | 2.82% | 分 |
| 8 | 康希诺 | 3.00% | -0.31% | 5.3分 |
| 10 | 卫光生物 | 2.12% | -3.23% | 5.2分 |
| 12 | 康辰药业 | 1.69% | -4.73% | 5.6分 |
| 14 | 赛伦生物 | -0.61% | -4.82% | 5.1分 |
| 16 | 西藏药业 | -0.86% | -0.35% | 5.8分 |
| 18 | *ST双成 | -2.67% | -3.95% | 5.7分 |
| 20 | 东宝生物 | -3.11% | -3.27% | 5.2分 |
| 22 | 成大生物 | -3.73% | -2.70% | 5.0分 |
| 24 | 三生国健 | -4.35% | -1.99% | 5.9分 |
| 26 | 天坛生物 | -5.42% | -2.64% | 4.9分 |
| 28 | - | -5.83% | -2.71% | 分 |
| 30 | 特宝生物 | -5.91% | -4.83% | 4.7分 |
| 32 | 甘李药业 | -6.04% | -3.50% | 5.5分 |
| 34 | 近岸蛋白 | -7.01% | -4.74% | 4.2分 |
| 36 | 百克生物 | -7.03% | -3.62% | 4.5分 |
| 38 | 迈威生物 | -7.47% | -2.12% | 4.7分 |
| 40 | 长春高新 | -7.50% | -5.05% | 4.9分 |
| 42 | 康弘药业 | -7.91% | -4.45% | 4.9分 |
| 44 | 沃森生物 | -9.39% | -5.50% | 4.3分 |
| 46 | 昊帆生物 | -9.86% | -6.09% | 4.2分 |
| 48 | 金迪克 | -12.44% | -3.62% | 4.1分 |
| 50 | 康华生物 | -14.90% | -9.66% | 4.2分 |
| 52 | 我武生物 | -15.57% | -8.43% | 4.4分 |
| 54 | 华兰疫苗 | -21.91% | -6.18% | 5.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 5/71 ， 24/71。
[{"date":"2025-09-30","value":"13.30","vol":"-9.78"},{"date":"2025-06-30","value":"9.06","vol":"-0.61"},{"date":"2025-03-31","value":"5.09","vol":"0.46"},{"date":"2024-12-31","value":"17.98","vol":"-0.68"},{"date":"2024-09-30","value":"15.37","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
13.30 | 9.06 | 5.09 | 17.98 | 15.37 |
| 行业(%) | -9.78 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"75.97","vol":"67.61"},{"date":"2025-06-30","value":"76.45","vol":"68.28"},{"date":"2025-03-31","value":"76.96","vol":"68.43"},{"date":"2024-12-31","value":"77.39","vol":"69.85"},{"date":"2024-09-30","value":"77.75","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
75.97 | 76.45 | 76.96 | 77.39 | 77.75 |
| 行业(%) | 67.61 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 29/71 ， 28/71。
[{"date":"2025-09-30","value":"2.15","vol":"45.25"},{"date":"2025-06-30","value":"-0.51","vol":"6902.04"},{"date":"2025-03-31","value":"-4.17","vol":"6125.27"},{"date":"2024-12-31","value":"-11.51","vol":"47.35"},{"date":"2024-09-30","value":"-4.95","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
2.15 | -0.51 | -4.17 | -11.51 | -4.95 |
| 行业(%) | 45.25 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-6.48","vol":"44.80"},{"date":"2025-06-30","value":"-11.92","vol":"5.44"},{"date":"2025-03-31","value":"-4.02","vol":"-8.46"},{"date":"2024-12-31","value":"-16.56","vol":"-9.81"},{"date":"2024-09-30","value":"-9.89","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-6.48 | -11.92 | -4.02 | -16.56 | -9.89 |
| 行业(%) | 44.80 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，居行业前列，两项指标的行业排名分别为 5/71 ， 6/71。
[{"date":"2025-09-30","value":"0.38","vol":"0.22"},{"date":"2025-06-30","value":"0.26","vol":"0.14"},{"date":"2025-03-31","value":"0.12","vol":"0.06"},{"date":"2024-12-31","value":"0.50","vol":"0.29"},{"date":"2024-09-30","value":"0.39","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.38 | 0.26 | 0.12 | 0.50 | 0.39 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.64","vol":"0.92"},{"date":"2025-06-30","value":"1.05","vol":"0.56"},{"date":"2025-03-31","value":"0.49","vol":"0.26"},{"date":"2024-12-31","value":"2.15","vol":"1.17"},{"date":"2024-09-30","value":"1.58","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.64 | 1.05 | 0.49 | 2.15 | 1.58 |
| 行业(次) | 0.92 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"35.71","vol":"1.84"},{"date":"2025-06-30","value":"18.27","vol":"-1377.61"},{"date":"2025-03-31","value":"31.05","vol":"-46.99"},{"date":"2024-12-31","value":"43.02","vol":"-11.33"},{"date":"2024-09-30","value":"34.56","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 35.71 | 18.27 | 31.05 | 43.02 | 34.56 |
| 行业 | 1.84 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.52","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.94","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.52 | - | 0.94 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 30/71 ， 32/71。
[{"date":"2025-09-30","value":"3.78","vol":"6.00"},{"date":"2025-06-30","value":"3.36","vol":"6.64"},{"date":"2025-03-31","value":"3.07","vol":"7.75"},{"date":"2024-12-31","value":"3.41","vol":"6.72"},{"date":"2024-09-30","value":"3.20","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
3.78 | 3.36 | 3.07 | 3.41 | 3.20 |
| 行业 | 6.00 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.05","vol":"4.84"},{"date":"2025-06-30","value":"2.63","vol":"5.30"},{"date":"2025-03-31","value":"2.61","vol":"6.35"},{"date":"2024-12-31","value":"2.95","vol":"5.40"},{"date":"2024-09-30","value":"2.70","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.05 | 2.63 | 2.61 | 2.95 | 2.70 |
| 行业 | 4.84 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 33/71 ， 33/71。
[{"date":"2025-09-30","value":"14.81","vol":"28.18"},{"date":"2025-06-30","value":"15.83","vol":"26.73"},{"date":"2025-03-31","value":"16.52","vol":"26.03"},{"date":"2024-12-31","value":"16.27","vol":"25.81"},{"date":"2024-09-30","value":"17.20","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
14.81 | 15.83 | 16.52 | 16.27 | 17.20 |
| 行业(%) | 28.18 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.18","vol":"0.58"},{"date":"2025-06-30","value":"0.20","vol":"1.11"},{"date":"2025-03-31","value":"0.21","vol":"0.78"},{"date":"2024-12-31","value":"0.20","vol":"0.87"},{"date":"2024-09-30","value":"0.22","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.18 | 0.20 | 0.21 | 0.20 | 0.22 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"2.07","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"7.03","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"8.47","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.07","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"7.56","blueLineValue":"0.45","type":"YC"}]